In human medicine, detection of CK19 mRNA-positive cells in peripheral blood using PCR technique is beneficial to identify early-stage breast cancer patients with micrometastatic diseases and used for prognostications such as poor survival rate, disease free interval and overall survival time7–11. Here, KRT19 is linked to breast carcinoma.